Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-016219
Filing Date
2022-06-03
Accepted
2022-06-03 17:26:26
Documents
1
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165429156325887.html 4  
1 FORM 4 wf-form4_165429156325887.xml 4 3502
  Complete submission text file 0001628280-22-016219.txt   4831
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Skovronsky Daniel (Reporting) CIK: 0001741474 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 22995816